PRLD vs VMC · rev $6.5M vs P/E 35, rev $7.42B
Prelude Therapeutics Inc (PRLD) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
PRLD currently screens at market cap $346.5M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the PRLD and VMC stock pages for the full models.
Not investment advice.